Evidence map›Paper›PMID 24004724›Full record

ArticleVirology journal2013

Possible antiviral effect of ciprofloxacin treatment on polyomavirus BK replication and analysis of non-coding control region sequences.

Ilaria Umbro, Elena Anzivino, Francesca Tinti, Assunta Zavatto, Anna Bellizzi, Donatella Maria Rodio, Carlo Mancini, Valeria Pietropaolo, Anna Paola Mitterhofer

Open access · goldAbstract readCase Reports
In one paragraph

Article in Virology journal, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.3field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. F1000Research · 2020
    Article
  3. Review
  4. Common viral infections in kidney transplant recipients.Kidney research and clinical practice · 2018
    Review
  5. Antiviral, antifungal, and antiparasitic activities of fluoroquinolones optimized for treatment of bacterial infections: a puzzling paradox or a logical consequence of their mode of action?European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2015
    Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 2 countries.

Ilaria UmbroDepartment of Clinical Medicine, Nephrology and Dialysis Unit, "Sapienza" University of Rome, Viale dell'Università 37, Rome 00185, Italy. annapaola.mitter@uniroma1.it.
Elena Anzivino
Francesca Tinti
Assunta Zavatto
Anna Bellizzi
Donatella Maria Rodio
Carlo Mancini
Valeria Pietropaolo
Anna Paola Mitterhofer
Sapienza University of Rome · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Acute renal dysfunction (ARD) is a common complication in renal transplant recipients. Multiple factors contribute to ARD development, including acute rejection and microbial infections. Many viral infections after kidney transplantation result from reactivation of "latent" viruses in the host or from the graft, such as the human Polyomavirus BK (BKV). We report the case of a 39 year-old recipient of a 2nd kidney graft who experienced BKV reactivation after a second episode of acute humoral rejection. A 10-day treatment with the quinolone antibiotic ciprofloxacin was administered with an increase of immunosuppressive therapy despite the active BKV replication. Real Time PCR analysis performed after treatment with ciprofloxacin, unexpectedly showed clearance of BK viremia and regression of BK viruria. During the follow-up, BK viremia persisted undetectable while viruria decreased further and disappeared after 3 months.BKV non-coding control region sequence analysis from all positive samples always showed the presence of archetypal sequences, with two single-nucleotide substitutions and one nucleotide deletion that, interestingly, were all representative of the subtype/subgroup I/b-1 we identified by the viral protein 1 sequencing analysis.We report the potential effect of the quinolone antibiotic ciprofloxacin in the decrease of the BKV load in both blood and urine.

Indexed as

DNA, IntergenicRegulatory Sequences, Nucleic AcidAdultAnti-Bacterial AgentsBK VirusCiprofloxacinDNA, ViralHumansKidney TransplantationMalePoint MutationPolyomavirus InfectionsReal-Time Polymerase Chain ReactionSequence DeletionTreatment OutcomeViremiaAnti-Bacterial AgentsCiprofloxacinDNA, IntergenicDNA, Viral

Identifiers

PMID24004724
PMCPMC3766702
OpenAlexW2117862111

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.